Skip to content
  • Home
  • About HAE
    • Board of Directors
  • HAE Management
  • Patient Resources
  • Medical Literature
  • Photo Gallery
  • Guidelines
  • Contact Us
  • Membership Application
  • Links
  • Events
CHAEN-RCAH
  • Home
  • About HAE
    • Board of Directors
  • HAE Management
  • Patient Resources
  • Medical Literature
  • Photo Gallery
  • Guidelines
CHAEN-RCAH

Lanadelumab (Takhzyro) for prevention of hereditary angioedema [Review]

  • Chris DawkinsChris Dawkins
  • March 15, 2022

Available from: https://secure.medicalletter.org/article-share?a=1619f&p=tml&title=Lanadelumab%20(Takhzyro)%20for%20Prevention%20of%20Hereditary%20Angioedema%20(online%20only)&cannotaccesstitle=1

Funding for Canadian Hereditary Angioedema Network has been generously provided by unrestricted grants from:

Contact Us

20 Carlton Street,
Suite 123
Toronto, ON M5B 2H5
Tel: 416-585-3000

Content of Note

  • Patient Resources
  • Medical Literature
  • Guidelines

Patient Images

Copyright © 2023
CHAEN-RCAH

All rights reserved.

Privacy Policy